# A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

> **NCT06722729** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 150 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** KDT-3594
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06722729
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06722729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06722729, "A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06722729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*